BPG is committed to discovery and dissemination of knowledge
Article Citation
Spera AM. Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review. World J Virol 2021; 10(2): 53-61 [PMID: 33816150 DOI: 10.5501/wjv.v10.i2.53]
Please LOGIN to submit a new comment.
Write to the Help Desk